{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:25:14Z","timestamp":1793305514020,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The theory of immunosurveillance posits that T cells eliminate clones harboring nonself-antigens generated by somatic mutations. Although a role of immunosurveillance in cancer is supported by evidence, whether it affects precancerous expansions has not been well established. Here we studied the association between MHC\u2013variant binding and risk of clonal hematopoiesis (CH), a blood precancer state, predicting MHC binding affinity toward CH hotspot variants in 380,000 UK Biobank participants and examining the relationship between predicted binding to each variant and its expansion risk. Despite the study being powered to detect subtle differences in selective pressure, we did not find associations between predicted binding and CH prevalence for any of the examined variants. In CH-affected individuals, we identified no relationship between predicted variant binding and clone size. Overall, we found no evidence that the MHC genotype affects which variants expand in CH, suggesting a limited role for immunosurveillance in shaping clonal expansions in the blood.<\/jats:p>","DOI":"10.1038\/s41588-026-02594-y","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T09:04:10Z","timestamp":1782723850000},"page":"1643-1650","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["No evidence of immunosurveillance in mutation-hotspot-driven clonal hematopoiesis"],"prefix":"10.1038","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1722-5897","authenticated-orcid":false,"given":"Barbara","family":"Walkowiak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6517-785X","authenticated-orcid":false,"given":"Hamish A. J.","family":"MacGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9747-7363","authenticated-orcid":false,"given":"Jamie R.","family":"Blundell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"2594_CR1","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1172\/JCI31405","volume":"117","author":"JB Swann","year":"2007","unstructured":"Swann, J. B. & Smyth, M. J. Immune surveillance of tumors. J. Clin. Invest. 117, 1137\u20131146 (2007).","journal-title":"J. Clin. Invest."},{"key":"2594_CR2","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","volume":"22","author":"N Pishesha","year":"2022","unstructured":"Pishesha, N., Harmand, T. J. & Ploegh, H. L. A guide to antigen processing and presentation. Nat. Rev. Immunol. 22, 751\u2013764 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"2594_CR3","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3389\/fimmu.2017.00292","volume":"8","author":"M Wieczorek","year":"2017","unstructured":"Wieczorek, M. et al. Major histocompatibility complex (MHC) class I and MHC class II proteins: conformational plasticity in antigen presentation. Front. Immunol. 8, 292 (2017).","journal-title":"Front. Immunol."},{"key":"2594_CR4","doi-asserted-by":"publisher","first-page":"D423","DOI":"10.1093\/nar\/gku1161","volume":"43","author":"J Robinson","year":"2015","unstructured":"Robinson, J. et al. The IPD and IMGT\/HLA database: allele variant databases. Nucleic Acids Res. 43, D423\u2013D431 (2015).","journal-title":"Nucleic Acids Res."},{"key":"2594_CR5","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.cell.2017.09.050","volume":"171","author":"R Marty","year":"2017","unstructured":"Marty, R. et al. MHC-I genotype restricts the oncogenic mutational landscape. Cell 171, 1272\u20131283 (2017).","journal-title":"Cell"},{"key":"2594_CR6","doi-asserted-by":"publisher","first-page":"eaba4380","DOI":"10.1126\/scitranslmed.aba4380","volume":"14","author":"M Gigoux","year":"2022","unstructured":"Gigoux, M. et al. Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine. Sci. Transl. Med. 14, eaba4380 (2022).","journal-title":"Sci. Transl. Med."},{"key":"2594_CR7","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.stem.2022.04.007","volume":"29","author":"P Hern\u00e1ndez-Malmierca","year":"2022","unstructured":"Hern\u00e1ndez-Malmierca, P. et al. Antigen presentation safeguards the integrity of the hematopoietic stem cell pool. Cell Stem Cell 29, 760\u2013775 (2022).","journal-title":"Cell Stem Cell"},{"key":"2594_CR8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41577-020-0390-6","volume":"21","author":"D Dersh","year":"2021","unstructured":"Dersh, D., Holl\u00fd, J. & Yewdell, J. W. A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion. Nat. Rev. Immunol. 21, 116\u2013128 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"2594_CR9","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.cell.2018.08.048","volume":"175","author":"RM Pyke","year":"2018","unstructured":"Pyke, R. M. et al. Evolutionary pressure against MHC class II binding cancer mutations. Cell 175, 416\u2013428 (2018).","journal-title":"Cell"},{"key":"2594_CR10","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41586-019-1671-8","volume":"574","author":"E Alspach","year":"2019","unstructured":"Alspach, E. et al. MHC-II neoantigens shape tumour immunity and response to immunotherapy. Nature 574, 696\u2013701 (2019).","journal-title":"Nature"},{"key":"2594_CR11","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41588-023-01313-1","volume":"55","author":"L Zapata","year":"2023","unstructured":"Zapata, L. et al. Immune selection determines tumor antigenicity and influences response to checkpoint inhibitors. Nat. Genet. 55, 451\u2013460 (2023).","journal-title":"Nat. Genet."},{"key":"2594_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-018-1434-0","volume":"19","author":"L Zapata","year":"2018","unstructured":"Zapata, L. et al. Negative selection in tumor genome evolution acts on essential cellular functions and the immunopeptidome. Genome Biol. 19, 67 (2018).","journal-title":"Genome Biol."},{"key":"2594_CR13","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni1102-991","volume":"3","author":"GP Dunn","year":"2002","unstructured":"Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J. & Schreiber, R. D. Cancer immunoediting: from immunosurveillance to tumor escape. Nat. Immunol. 3, 991\u2013998 (2002).","journal-title":"Nat. Immunol."},{"key":"2594_CR14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41586-022-04735-9","volume":"606","author":"M \u0141uksza","year":"2022","unstructured":"\u0141uksza, M. et al. Neoantigen quality predicts immunoediting in survivors of pancreatic cancer. Nature 606, 389\u2013395 (2022).","journal-title":"Nature"},{"key":"2594_CR15","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nature24473","volume":"551","author":"M \u0141uksza","year":"2017","unstructured":"\u0141uksza, M. et al. A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy. Nature 551, 517\u2013520 (2017).","journal-title":"Nature"},{"key":"2594_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10497-4","volume":"23","author":"S Ilham","year":"2023","unstructured":"Ilham, S. et al. Cancer incidence in immunocompromised patients: a single-center cohort study. BMC Cancer 23, 33 (2023).","journal-title":"BMC Cancer"},{"key":"2594_CR17","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41586-021-03965-7","volume":"598","author":"B Colom","year":"2021","unstructured":"Colom, B. et al. Mutant clones in normal epithelium outcompete and eliminate emerging tumours. Nature 598, 510\u2013514 (2021).","journal-title":"Nature"},{"key":"2594_CR18","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.cell.2017.09.042","volume":"171","author":"I Martincorena","year":"2017","unstructured":"Martincorena, I. et al. Universal patterns of selection in cancer and somatic tissues. Cell 171, 1029\u20131041 (2017).","journal-title":"Cell"},{"key":"2594_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22890-x","volume":"12","author":"H Dejima","year":"2021","unstructured":"Dejima, H. et al. Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features. Nat. Commun. 12, 2722 (2021).","journal-title":"Nat. Commun."},{"key":"2594_CR20","doi-asserted-by":"publisher","first-page":"e41090","DOI":"10.7554\/eLife.41090","volume":"7","author":"RS Gejman","year":"2018","unstructured":"Gejman, R. S. et al. Rejection of immunogenic tumor clones is limited by clonal fraction. eLife 7, e41090 (2018).","journal-title":"eLife"},{"key":"2594_CR21","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","volume":"371","author":"G Genovese","year":"2014","unstructured":"Genovese, G. et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N. Engl. J. Med. 371, 2477\u20132487 (2014).","journal-title":"N. Engl. J. Med."},{"key":"2594_CR22","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"371","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal, S. et al. Age-related clonal hematopoiesis associated with adverse outcomes. N. Engl. J. Med. 371, 2488\u20132498 (2014).","journal-title":"N. Engl. J. Med."},{"key":"2594_CR23","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203\u2013209 (2018).","journal-title":"Nature"},{"key":"2594_CR24","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","volume":"48","author":"B Reynisson","year":"2020","unstructured":"Reynisson, B., Alvarez, B., Paul, S., Peters, B. & Nielsen, M. NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Res. 48, W449\u2013W454 (2020).","journal-title":"Nucleic Acids Res."},{"key":"2594_CR25","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1126\/science.aay9333","volume":"367","author":"CJ Watson","year":"2020","unstructured":"Watson, C. J. et al. The evolutionary dynamics and fitness landscape of clonal hematopoiesis. Science 367, 1449\u20131454 (2020).","journal-title":"Science"},{"key":"2594_CR26","doi-asserted-by":"publisher","first-page":"eadi3808","DOI":"10.1126\/science.adi3808","volume":"383","author":"C Krishna","year":"2024","unstructured":"Krishna, C. et al. An immunogenetic basis for lung cancer risk. Science 383, eadi3808 (2024).","journal-title":"Science"},{"key":"2594_CR27","doi-asserted-by":"publisher","first-page":"104588","DOI":"10.1016\/j.ebiom.2023.104588","volume":"92","author":"Q-L Wang","year":"2023","unstructured":"Wang, Q.-L. et al. Association of HLA diversity with the risk of 25 cancers in the UK Biobank. eBioMedicine 92, 104588 (2023).","journal-title":"eBioMedicine"},{"key":"2594_CR28","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/j.stem.2023.09.013","volume":"30","author":"M Kasbekar","year":"2023","unstructured":"Kasbekar, M., Mitchell, C. A., Proven, M. A. & Passegu\u00e9, E. Hematopoietic stem cells through the ages: a lifetime of adaptation to organismal demands. Cell Stem Cell 30, 1403\u20131420 (2023).","journal-title":"Cell Stem Cell"},{"key":"2594_CR29","doi-asserted-by":"publisher","first-page":"eadj6367","DOI":"10.1126\/sciadv.adj6367","volume":"9","author":"JB Nilsson","year":"2023","unstructured":"Nilsson, J. B. et al. Accurate prediction of HLA class II antigen presentation across all loci using tailored data acquisition and refined machine learning. Sci. Adv. 9, eadj6367 (2023).","journal-title":"Sci. Adv."},{"key":"2594_CR30","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cels.2022.12.002","volume":"14","author":"D Gfeller","year":"2023","unstructured":"Gfeller, D. et al. Improved predictions of antigen presentation and TCR recognition with MixMHCpred2.2 and PRIME2.0 reveal potent SARS-CoV-2 CD8+ T-cell epitopes. Cell Syst. 14, 72\u201383 (2023).","journal-title":"Cell Syst."},{"key":"2594_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08304-z","volume":"10","author":"G Cafri","year":"2019","unstructured":"Cafri, G. et al. Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients. Nat. Commun. 10, 449 (2019).","journal-title":"Nat. Commun."},{"key":"2594_CR32","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMoa1609279","volume":"375","author":"E Tran","year":"2016","unstructured":"Tran, E. et al. T-cell transfer therapy targeting mutant KRAS in cancer. N. Engl. J. Med. 375, 2255\u20132262 (2016).","journal-title":"N. Engl. J. Med."},{"key":"2594_CR33","unstructured":"Lindner, K. Identification and Validation of Neoepitope-Specific T Cell Receptors for Glioma Immunotherapy. Dissertation, Ruprecht Karl Univ. Heidelberg (2023)."},{"key":"2594_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25605-4","volume":"12","author":"MS Hwang","year":"2021","unstructured":"Hwang, M. S. et al. Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens. Nat. Commun. 12, 5271 (2021).","journal-title":"Nat. Commun."},{"key":"2594_CR35","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1182\/blood.2023021979","volume":"143","author":"WK Leung","year":"2024","unstructured":"Leung, W. K. et al. Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia. Blood 143, 1726\u20131737 (2024).","journal-title":"Blood"},{"key":"2594_CR36","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1158\/2326-6066.CIR-22-0040","volume":"10","author":"SP Kim","year":"2022","unstructured":"Kim, S. P. et al. Adoptive cellular therapy with autologous tumor-infiltrating lymphocytes and T-cell receptor\u2013engineered T cells targeting common p53 neoantigens in human solid tumors. Cancer Immunol. Res. 10, 932\u2013946 (2022).","journal-title":"Cancer Immunol. Res."},{"key":"2594_CR37","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1158\/2326-6066.CIR-18-0686","volume":"7","author":"W Lo","year":"2019","unstructured":"Lo, W. et al. Immunologic recognition of a shared p53 mutated neoantigen in a patient with metastatic colorectal cancer. Cancer Immunol. Res. 7, 534\u2013543 (2019).","journal-title":"Cancer Immunol. Res."},{"key":"2594_CR38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.exphem.2020.09.200","volume":"92","author":"M Ivanova","year":"2020","unstructured":"Ivanova, M. et al. Probable HLA-mediated immunoediting of JAK2 V617F-driven oncogenesis. Exp. Hematol. 92, 75\u201388 (2020).","journal-title":"Exp. Hematol."},{"key":"2594_CR39","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.cell.2019.08.032","volume":"179","author":"Y Wolf","year":"2019","unstructured":"Wolf, Y. et al. UVB-induced tumor heterogeneity diminishes immune response in melanoma. Cell 179, 219\u2013235 (2019).","journal-title":"Cell"},{"key":"2594_CR40","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1016\/j.immuni.2023.07.018","volume":"56","author":"LL Cao","year":"2023","unstructured":"Cao, L. L. & Kagan, J. C. Targeting innate immune pathways for cancer immunotherapy. Immunity 56, 2206\u20132217 (2023).","journal-title":"Immunity"},{"key":"2594_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13195-1","volume":"10","author":"J Hausser","year":"2019","unstructured":"Hausser, J. et al. Tumor diversity and the trade-off between universal cancer tasks. Nat. Commun. 10, 5423 (2019).","journal-title":"Nat. Commun."},{"key":"2594_CR42","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41586-022-04696-z","volume":"606","author":"D Hoyos","year":"2022","unstructured":"Hoyos, D. et al. Fundamental immune\u2013oncogenicity trade-offs define driver mutation fitness. Nature 606, 172\u2013179 (2022).","journal-title":"Nature"},{"key":"2594_CR43","doi-asserted-by":"publisher","unstructured":"Nguyen, A., Nellore, A. & Thompson, R. F. Discordant results among MHC binding affinity prediction tools. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2022.12.04.518984 (2022).","DOI":"10.1101\/2022.12.04.518984"},{"key":"2594_CR44","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/annonc\/mdx687","volume":"29","author":"E Ghorani","year":"2018","unstructured":"Ghorani, E. et al. Differential binding affinity of mutated peptides for MHC class I is a predictor of survival in advanced lung cancer and melanoma. Ann. Oncol. 29, 271\u2013279 (2018).","journal-title":"Ann. Oncol."},{"key":"2594_CR45","doi-asserted-by":"publisher","first-page":"103850","DOI":"10.1016\/j.isci.2022.103850","volume":"25","author":"Z Ko\u015falo\u011flu-Yal\u00e7\u0131n","year":"2022","unstructured":"Ko\u015falo\u011flu-Yal\u00e7\u0131n, Z. et al. Combined assessment of MHC binding and antigen abundance improves T cell epitope predictions. iScience 25, 103850 (2022).","journal-title":"iScience"},{"key":"2594_CR46","doi-asserted-by":"publisher","unstructured":"Nibeyro, G. et al. MHC-I binding affinity derived metrics fail to predict tumor specific neoantigen immunogenicity. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2022.03.14.484285 (2022).","DOI":"10.1101\/2022.03.14.484285"},{"key":"2594_CR47","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1038\/s43018-023-00675-z","volume":"4","author":"H O\u2019Brien","year":"2023","unstructured":"O\u2019Brien, H. et al. Breaking the performance ceiling for neoantigen immunogenicity prediction. Nat. Cancer 4, 1618\u20131621 (2023).","journal-title":"Nat. Cancer"},{"key":"2594_CR48","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00262-019-02473-y","volume":"69","author":"MO Holmstr\u00f6m","year":"2020","unstructured":"Holmstr\u00f6m, M. O. et al. Evidence of immune elimination, immuno-editing and immune escape in patients with hematological cancer. Cancer Immunol. Immunother. 69, 315\u2013324 (2020).","journal-title":"Cancer Immunol. Immunother."},{"key":"2594_CR49","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.ccell.2023.03.003","volume":"41","author":"SA Rosenberg","year":"2023","unstructured":"Rosenberg, S. A., Parkhurst, M. R. & Robbins, P. F. Adoptive cell transfer immunotherapy for patients with solid epithelial cancers. Cancer Cell 41, 646\u2013648 (2023).","journal-title":"Cancer Cell"},{"key":"2594_CR50","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aam7729","volume":"10","author":"A Prestipino","year":"2018","unstructured":"Prestipino, A. et al. Oncogenic JAK2V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms. Sci. Transl. Med. 10, eaam7729 (2018).","journal-title":"Sci. Transl. Med."},{"key":"2594_CR51","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/leu.2016.290","volume":"31","author":"MO Holmstr\u00f6m","year":"2017","unstructured":"Holmstr\u00f6m, M. O. et al. The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms. Leukemia 31, 495\u2013498 (2017).","journal-title":"Leukemia"},{"key":"2594_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54711-2","volume":"15","author":"J Kreger","year":"2024","unstructured":"Kreger, J., Mooney, J. A., Shibata, D. & MacLean, A. L. Developmental hematopoietic stem cell variation explains clonal hematopoiesis later in life. Nat. Commun. 15, 10268 (2024).","journal-title":"Nat. Commun."},{"key":"2594_CR53","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/s41591-022-01793-4","volume":"28","author":"N Sousos","year":"2022","unstructured":"Sousos, N. et al. In utero origin of myelofibrosis presenting in adult monozygotic twins. Nat. Med. 28, 1207\u20131211 (2022).","journal-title":"Nat. Med."},{"key":"2594_CR54","doi-asserted-by":"publisher","unstructured":"Watson, C. J. et al. Evolutionary dynamics in the decades preceding acute myeloid leukaemia. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.07.05.602251 (2024).","DOI":"10.1101\/2024.07.05.602251"},{"key":"2594_CR55","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41586-021-04312-6","volume":"602","author":"N Williams","year":"2022","unstructured":"Williams, N. et al. Life histories of myeloproliferative neoplasms inferred from phylogenies. Nature 602, 162\u2013168 (2022).","journal-title":"Nature"},{"key":"2594_CR56","doi-asserted-by":"publisher","first-page":"20143085","DOI":"10.1098\/rspb.2014.3085","volume":"282","author":"AK Simon","year":"2015","unstructured":"Simon, A. K., Hollander, G. A. & McMichael, A. Evolution of the immune system in humans from infancy to old age. Proc. R. Soc. B 282, 20143085 (2015).","journal-title":"Proc. R. Soc. B"},{"key":"2594_CR57","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry, E. J. T cell exhaustion. Nat. Immunol. 12, 492\u2013499 (2011).","journal-title":"Nat. Immunol."},{"key":"2594_CR58","doi-asserted-by":"publisher","first-page":"e1009368","DOI":"10.1371\/journal.pgen.1009368","volume":"17","author":"A Claeys","year":"2021","unstructured":"Claeys, A., Luijts, T., Marchal, K. & Van den Eynden, J. Low immunogenicity of common cancer hot spot mutations resulting in false immunogenic selection signals. PLoS Genet. 17, e1009368 (2021).","journal-title":"PLoS Genet."},{"key":"2594_CR59","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1038\/s41588-021-00935-7","volume":"53","author":"Y Luo","year":"2021","unstructured":"Luo, Y. et al. A high-resolution HLA reference panel capturing global population diversity enables multi-ancestry fine-mapping in HIV host response. Nat. Genet. 53, 1504\u20131516 (2021).","journal-title":"Nat. Genet."},{"key":"2594_CR60","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan4673","volume":"366","author":"S Jaiswal","year":"2019","unstructured":"Jaiswal, S. & Ebert, B. L. Clonal hematopoiesis in human aging and disease. Science 366, eaan4673 (2019).","journal-title":"Science"},{"key":"2594_CR61","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1038\/s41591-024-03213-1","volume":"30","author":"M D\u00edez-D\u00edez","year":"2024","unstructured":"D\u00edez-D\u00edez, M. et al. Unidirectional association of clonal hematopoiesis with atherosclerosis development. Nat. Med. 30, 2857\u20132866 (2024).","journal-title":"Nat. Med."},{"key":"2594_CR62","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0140-6736(12)60404-8","volume":"379","author":"R Collins","year":"2012","unstructured":"Collins, R. What makes UK Biobank special?. Lancet 379, 1173\u20131174 (2012).","journal-title":"Lancet"},{"key":"2594_CR63","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow, C. et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLOS Med. 12, e1001779 (2015).","journal-title":"PLOS Med."},{"key":"2594_CR64","unstructured":"Motyer, A., Vukcevic, D., Cortes, A., McVean, G. & Leslie, S. Imputation of Classical HLA Types from UK Biobank Genotype Data (UK Biobank, 2016)."},{"key":"2594_CR65","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41586-021-04103-z","volume":"599","author":"JD Backman","year":"2021","unstructured":"Backman, J. D. et al. Exome sequencing and analysis of 454,787 UK Biobank participants. Nature 599, 628\u2013634 (2021).","journal-title":"Nature"},{"key":"2594_CR66","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213\u2013219 (2013).","journal-title":"Nat. Biotechnol."},{"key":"2594_CR67","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41586-018-0321-x","volume":"559","author":"P-R Loh","year":"2018","unstructured":"Loh, P.-R. et al. Insights about clonal hematopoiesis from 8,342 mosaic chromosomal alterations. Nature 559, 350\u2013355 (2018).","journal-title":"Nature"},{"key":"2594_CR68","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-020-00710-0","volume":"52","author":"KL Bolton","year":"2020","unstructured":"Bolton, K. L. et al. Cancer therapy shapes the fitness landscape of clonal hematopoiesis. Nat. Genet. 52, 1219\u20131226 (2020).","journal-title":"Nat. Genet."},{"key":"2594_CR69","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate, J. G. et al. COSMIC: the Catalogue Of Somatic Mutations In Cancer. Nucleic Acids Res. 47, D941\u2013D947 (2019).","journal-title":"Nucleic Acids Res."},{"key":"2594_CR70","doi-asserted-by":"publisher","unstructured":"the-blundell-lab\/MHC_ClonalHaematopoiesis: first release (version v1). Zenodo. https:\/\/doi.org\/10.5281\/zenodo.17348768 (2025).","DOI":"10.5281\/zenodo.17348768"}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41588-026-02594-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-026-02594-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-026-02594-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T16:02:45Z","timestamp":1783958565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41588-026-02594-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":70,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2594"],"URL":"https:\/\/doi.org\/10.1038\/s41588-026-02594-y","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"27 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}